DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Ellis HP, Kurian KM.
Biological Rationale for the Use of PPARgamma Agonists in Glioblastoma.
Front Oncol 2014;
4: 52 doi:10.3389/fonc.2014.00052
We do not assume any responsibility for the contents of the web pages of other providers.